Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-06-16 @ 6:27 PM
Study NCT ID:
NCT07226700
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-10
First Post:
2025-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Suzetrigine in Total Hip Arthroplasty
Sponsor:
Hospital for Special Surgery, New York
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Total Hip Arthroplasty (THA) | View |
| None | Total Hip Arthroplasty \(THA\) | View |
| None | Total Hip Replacement | View |
| None | Total Hip Replacement Surgery | View |
| None | Total Hip Replacements | View |
| None | Total Hip Replacement Arthroplasty | View |
| None | Suzetrigine | View |
| None | Pain Management | View |
| None | Pain | View |
| None | Nav 1.8 | View |
| None | JOURNAVX | View |
| None | Opioid Cessation | View |
| None | Opioid Consumption, Postoperative | View |
| None | Multimodal Analgesia | View |
| None | Randomized Controlled Trial | View |
| None | Randomized Controlled Study | View |
| None | Randomized Controlled Trials | View |
Keywords: